Inheritance and clinical outcome in childhood acute lymphoblastic leukemia

被引：0
作者：
Jamroziak, Krzysztof [1 ]
Robak, Tadeusz [1 ]
机构：
[1] Med Univ Lodz, Dept Hematol, PL-93513 Lodz, Poland
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 07期
关键词：
Genetic polymorphisms; Pharmacogenetics; Pharmacogenomics; Xenobiotic metabolizing enzymes; Childhood acute lymphoblastic leukemia; XENOBIOTIC-METABOLIZING ENZYMES; THYMIDYLATE SYNTHASE GENE; PHARMACOGENOMICS; POLYMORPHISMS;
D O I：
10.1016/j.leukres.2009.01.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：889 / 890
页数：2
相关论文
共 50 条
[21]   Anemia and survival in childhood acute lymphoblastic leukemia [J].
Teuffel, Oliver ;
Stanulla, Martin ;
Cario, Gunnar ;
Ludwig, Wolf D. ;
Rottgers, Silja ;
Schafer, Beat W. ;
Zimmermann, Martin ;
Schrappe, Martin ;
Niggli, Felix K. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (11) :1652-1657
[22]   Genetic susceptibility to childhood acute lymphoblastic leukemia [J].
Sinnett, D ;
Krajinovic, M ;
Labuda, D .
LEUKEMIA & LYMPHOMA, 2000, 38 (5-6) :447-+
[23]   Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia [J].
Ansari, M. ;
Sauty, G. ;
Labuda, M. ;
Gagne, V. ;
Rousseau, J. ;
Moghrabi, A. ;
Laverdiere, C. ;
Sinnett, D. ;
Krajinovic, M. .
PHARMACOGENOMICS JOURNAL, 2012, 12 (05) :386-394
[24]   Allelic loss in childhood acute lymphoblastic leukemia [J].
Baccichet, A ;
Qualman, SK ;
Sinnett, D .
LEUKEMIA RESEARCH, 1997, 21 (09) :817-823
[25]   Therapies on the horizon for childhood acute lymphoblastic leukemia [J].
Carroll, William L. ;
Hunger, Stephen P. .
CURRENT OPINION IN PEDIATRICS, 2016, 28 (01) :12-18
[26]   The outcomes of childhood acute lymphoblastic leukemia with hyperleukocytosis [J].
Alfina, Din ;
Widjajanto, Pudjo Hagung ;
Patria, Suryono Yudha .
PAEDIATRICA INDONESIANA, 2018, 58 (04) :186-191
[27]   Residual disease in acute lymphoblastic leukemia of childhood: Methods of detection and clinical relevance [J].
Faderl, S ;
Estrov, Z .
CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (02) :73-85
[28]   Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment [J].
Pavlovic, Sonja ;
Kotur, Nikola ;
Stankovic, Biljana ;
Zukic, Branka ;
Gasic, Vladimir ;
Dokmanovic, Lidija .
GENES, 2019, 10 (03)
[29]   Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia [J].
Ansari, Marc ;
Sauty, Geraldine ;
Labuda, Malgorzata ;
Gagne, Vincent ;
Laverdiere, Caroline ;
Moghrabi, Albert ;
Sinnett, Daniel ;
Krajinovic, Maja .
BLOOD, 2009, 114 (07) :1383-1386
[30]   Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia [J].
Radtke, Susanne ;
Zolk, Oliver ;
Renner, Bertold ;
Paulides, Marios ;
Zimmermann, Martin ;
Moericke, Anja ;
Stanulla, Martin ;
Schrappe, Martin ;
Langer, Thorsten .
BLOOD, 2013, 121 (26) :5145-5153
12345